Paracoccidioidomycosis.
Paracoccidioidomycosis is a fungal infection that is relatively common in Brazil, Venezuela, Colombia, Ecuador, and Argentina. Sporadic cases can also be seen in some other countries. It is caused by a dimorphic fungus, Paracoccidioides brasiliensis, which affects mainly the skin, lymph nodes, lungs, and oral, nasal, and gastrointestinal mucous membranes. Depending on the specific immunity of the host, the infection can assume many forms and affect single or multiple organs, eventually becoming a severe and even fatal disease. It is very important for dermatologists of all over the world to know about paracoccidioidomycosis because sometimes the disease only manifests many years after the individual has left the endemic area.
Ramos-E-Silva
Marcia
M
Sector of Dermatology and Post-Graduation Course in Dermatology, University Hospital HUCFF/UFRJ and School of Medicine, Universidade Federal do Rio de Janeiro, Rua Dona Mariana 143/C-32, 22280-020, Rio de Janeiro, Brazil. ramos.e.silva@dermato.med.br
Saraiva
Luciana do Espirito Santo
Ldo E
D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007818:Laryngeal Diseases / Q000188:drug therapy / Q000382:microbiology; D008172:Lung Diseases, Fungal / Q000188:drug therapy / Q000382:microbiology; D009059:Mouth Diseases / Q000188:drug therapy / Q000382:microbiology; D010228:Paracoccidioides / Q000302:isolation & purification*; D010229:Paracoccidioidomycosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D012307:Risk Factors; D013020:South America / Q000453:epidemiology; D014456:Ulcer / Q000188:drug therapy / Q000382:microbiology
D000981:Antiprotozoal Agents